Oppenheimer Maintains Outperform on RXO, Raises Price Target to $31
Portfolio Pulse from Benzinga Newsdesk
Oppenheimer analyst Scott Schneeberger maintains an Outperform rating on RXO (NYSE:RXO) and raises the price target from $22 to $31.
August 08, 2024 | 2:28 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Oppenheimer analyst Scott Schneeberger maintains an Outperform rating on RXO and raises the price target from $22 to $31.
The raised price target from $22 to $31 and the maintained Outperform rating by a reputable analyst is likely to positively impact RXO's stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100